טוען...
Endocrine Therapy in Early Breast Cancer
BACKGROUND: Endocrine therapy with a standard duration of 5 years is well known as an effective treatment for endocrine-sensitive breast cancer. SUMMARY: In the adjuvant setting this treatment reduces the 15-year mortality rates by about 30 and 40% with tamoxifen and aromatase inhibitor, respectivel...
שמור ב:
| הוצא לאור ב: | Breast Care (Basel) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
S. Karger GmbH
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7490651/ https://ncbi.nlm.nih.gov/pubmed/32982643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509362 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|